SHALBY INVESTOR RELATIONS
Shalby Limited 
| Registered Office | |
|---|---|
| Name | Shalby Limited | 
| Address | Opp. Karnawati Club,Sarkhej Gandhinagar Highway,Near Prahlad Nagar Garden,Ahmedabad –380 015, Gujarat, India | 
| Phone | +91 79 4020 3000 | 
| Fax | +91 79 4020 3120 | 
| CIN | L85110GJ2004PLC044667 | 
| Grievance Redressal & Nodal Officer | |
|---|---|
| Name | Mr. Tushar Shah (Associate Vice President and Company Secretary) | 
| Companysecretary@shalby.in | |
| Phone | +91 79 4020 3000 / +91 79 40203296 | 
| Online DisputeResolution ODR | |
| Investor Relations | |
|---|---|
| Name | Mr. Jigar Todi | 
| ircs3.corp@shalby.org | |
| Phone | +91 9512049871 | 
| Registrar & Transfer Agent | |
|---|---|
| Name | KFIN Technologies Limited | 
| Address | Selenium Building, Tower-B, Plot No 31 & 32,Financial District, Nanakramguda, Serilingampally,Hyderabad, Rangareddy, Telangana India - 500 032. | 
| einward.ris@kfintech.com | |
| Phone | 1800 309 4001 | 
| +91 910 009 4099 | |
| KPRISM | |
| KFIN Corporate Website Link | |
| Corporate Registry (RIS) WebsiteLink | |
| Investor SupportCentre Link | |
Investors
For Investors holding shares in Physical mode
If you have any dispute against a listed company and or its Registrar and Share Transfer Agent(RTA) on delay or defaultin processing your request, as per SEBIcircular dated 30.05.2022 ,you can file for arbitration with Stock Exchange.
Notice is hereby given that pursuant to the Securities and Exchange Board of India (“SEBI”) circular SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated 02nd July, 2025 (“SEBI Circular”), a Special window has been opened for a period of 6 (six) months from 07th July, 2025 till 06th January, 2026 (“said period”) for the shareholders for re-lodgement of transfer deeds, which were lodged prior to the deadline of 01st April, 2019 and rejected / returned / not attended to due to deficiency in the documents / process / or otherwise. The eligible shareholders may submit their request to the Company at companysecretary@shalby.in or Registrar and Share Transfer Agent (KFin Technologies Limited) at einward.ris@kfintech.com.
During the said period, the shares that are re-lodged for transfer shall be issued only in dematerialized (demat) mode. Due process shall be followed for such transfer-cum-demat requests. The SEBI Circular can be accessed at: SEBI Circular
21th AGM Notice 2024-25
BRSR Report 2024-25
Q3 FY 2025 Press Release
Q2 FY 2025 Press Release
Strategic Clinical Trial Agreement with Monogram Technologies, Inc.
Q1 FY 2025 Press Release
Q4 FY 2024 Press Release
Strategic Investment in Healers Hospital Pvt. Ltd. Gurugram with an acquisition of 100% equity stake
Q3 FY 2024 Press Release
 Acquisition of Majority Stake in Sanar International Hospitals, Gurugram, (PK Healthcare Pvt. Ltd)
Q2 FY 2024 Press Release
Q1 FY 2024 Press Release
Q4 FY 2023 Press Release
Q3 FY 2023 Press Release
Q2 FY 2023 Press Release
Q1 FY2023 Results Press Release
Launch of TUKS – A New Innovative Knee Implant
Q4 FY2022 Results Press Release
Q3 FY2022 Results Press Release
Q2 FY2022 Results Press Release
Q1 FY2022 Results Press Release
Acquired Implant Assets From Consensus Orthopedics(May 2021)
Shalby Limited Q2 FY2021
Shalby Limited Q3 FY2021
Q2 FY2020 Financial Results
India Facing Knee Arthritis Epidemic (Nov 2018)
Ovarian Mass Removal Jaipur (Sep 2018)
MoU with Sen Sok Intl Hospital, Cambodia (Apr 2018)
 Newspaper Adverisement - 100 days campaign and special window for relodgement of shares
 Report on transfer requests of Physical Shares Re-Lodged under the Special Window
 Resignation of Mr. Amit Pathak as Chief Financial Officer
 ESG Ratings Assigned by Crisil ESG Ratings & Analytics
 Disclosure under Reg. 74(5) of SEBI (DP) Regulations - Q2 FY 2025-26
 Outcome of 21st Annual General Meeting
 Trading Window Closure for Q2 FY 2025-26
 Special Window for Re-lodgement of Transfer Requests of Physical Shares
 Letter to shareholders (not having email) for sharing the weblink of Annual Report 2024-25
 BRSR Report 2024-25
 21st Annual Report 2024-25
 21st AGM Notice
 Analyst Meet
 Meeting with an Investor - Analyst meet
 Intimation for participation in Investor Conference - Ashwamedh - Elara India Dialogue
 Issuance of Corporate Guarantee for Lease Rental facilities granted to Shalby Medtech Limited
 Notice of 21st Annual General Meeting - Newspaper publication
 Exercise of 1,000 Employee Stock Options under Shalby Ltd Employees Stock Option Scheme-2021
 Schedule of Analyst/Investor Meet
 Intimation of AGM, Book closure, e-voting
 Audio Recording - Earnigs Conference call Q1 FY 2026
 Grant of ESOP under Shalby Limited Employee Stock Options Scheme- 2021
 Earnings Conference Call for Q1 FY2026 Intimation
 Saksham Niveshak – 100 days Campaign
 Petition filed against PK Healthcare (subsidiary of the Company) by minority Shareholders of PK Healthcare
 Press Release - World’s First Fully Autonomous Robotic Joint Replacement Surgery Performed at Shalby Multi‐Specialty Hospitals
 Exercise of 1,000 Employee Stock Options under Shalby Ltd Employees Stock Option Scheme-2021
 Exercise of 26,000 Employee Stock Options under Shalby Ltd Employees Stock Option Scheme-2021
 Shalby Ltd. and SVVV Indore Forge Strategic Partnership to Launch Healthcare Management Programs
 Reconciliation of Share Capital Audit Q1 FY 2025-26
 Disclosure under Reg. 74(5) of SEBI (DP) Regulations - Q1 FY 2025-26
 Notice of Trading Window Closure Q1FY26
 AACI Acreditation Krishna Shalby
 Credit Ratings - Others
 Audio Recording of the Earnings Conference Call for Q4FY2025
 Appointment of Secretarial Auditor for 5 years
 Grant of ESOP under Shalby Limited Employee Stock Options Scheme- 2021
 Schedule of Earnings Conference call to discuss Q4 FY 2025 earnings
 Annual Secretarial Compliance Report for financial year ended March 31, 2025
 Reconciliation of Share Capital Audit Q4 FY 2024-25
 Disclosure under Reg. 74(5) of SEBI (DP) Regulations - Q4 FY 2024-25
 Disclosure u/r. 31(4) of SEBI SAST
 Allotment of Equity Shares by Shalby Medtech Ltd to Shalby Ltd
 Termination Franchise Agreement Ranchi
 Closure of Trading Window - Q4 FY 2024-25
 Credit Rating
 Receipt of Hand Transplant Approval
 Postal Ballot Notice
 Demand Order by Office of Goods and Service Tax & Central Excise
 Audio Recording of Earnings Call-05-02-2025
 Grant of ESOP under Shalby Limited Employee Stock Options Scheme- 2021
 Integrated Filing - Financials for Q3 FY 2024-25
 Re-appointment of Dr. Vikram Shah as Chairman and Managing Director
 Schedule of Earning Conference call to discuss Q3FY25 earnings on 5th February 2025 at 2:30 pm. IST
 Inauguration of Shalby Tissue & Bone Bank at Krishna Shalby Hospital, Ahmedabad
 Shalby Advanced Technologies (SAT) Inc., USA received US FDA approval for its Product
 Reconciliation of Share Capital Audit for Q3 FY 2024-25
 Disclosure under Reg. 74(5) of SEBI (DP) Regulations - Q3 FY 2025
 Closure of Trading Window - Q3 FY 2024-25
 Exercise of 1000 Stock Options under Shalby Limited Employees Stock Option Scheme – 2021
 Disclosure under regulation 29(2) of SEBI (SAST) Regulations, 2011
 Disclosure under regulation 7(2) of SEBI (PIT) Regulations, 2015
 Exercise of 3000 Stock Options under Shalby Limited Employee Stock Option Scheme – 2021
 Audio Recording of Conference Call - 30-10-2024
 Schedule of Earning Conference call to discuss Q2FY25 earnings on 30th October 2024 at 5:30 pm. IST
 Resignation of Chief Marketing Officer
 Reconciliation of Share Capital Audit for Q2 FY 2024-25
 Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 - Q2 FY 2025
 Shalby Sanar International Hospitals honored with AACI International Accreditation
 Receipt of Prestigious Award “Best Hospital Chain of the Year (West)
 Outcome of 20th Annual General Meeting of the Company
 Closure of Trading Window - Q2 FY 2024-25
 Receipt of Bone Bank License
 Business Responsibility and Sustainability Report (BRSR)
 Notice of 20th Annual General Meeting
 Newspaper Advertisement for AGM
 Resignation of Senior Management Personnel
 Appointment of Chief Marketing Officer
 Grant of 60,000 Stock Options under Shalby Limited Employee Stock Option Scheme-2021
 Exercise of 2000 Stock Options under Shalby Limited Employee Stock Option Scheme – 2021
 Availing Term Loan of Rs. 600 million from HDFC Bank Ltd.
 Inauguration of Shalby Orthopedic Center of Excellence at Rajkot
 Exercise of 4000 Stock Options under Shalby Limited Employee Stock Option Scheme-2021
 Grant of 85,500 Stock Options under Shalby Limited Employee Stock Option Scheme-2021
 Exercise of 2000 Stock Options under Shalby Limited Employee Stock Option Scheme-2021
 Grant of 40,000 Stock Options under Shalby Limited Employee Stock Option Scheme-2021
 Receipt of order of Hon’ble Charity Commissioner, Maharashtra State, Mumbai
 Reconciliation of Share Capital Audit for Q1 FY 2024-25
 Audio Recording of Conference Call - 09-07-2024
 Re‐appointment of Mr. Shanay Shah, to hold office or place of profit
 Change in mode of Investor Conference Call scheduled on July 9, 2024.
 Certificate UR 74(5) of SEBI (DP) Regulations, 2018 - Q1 FY 2025
 Schedule of Investor Conference Call to discuss Q1 FY 2024-25 results – 9th July 2024
 Closure of Trading Window for Q1 FY 2024-25
 Termination of Franchise Agreement with Madhuban Orthopedic and Multispecialty Surgical Hospital Private Limited, Udaipur
 Availing SBLC & Working Capital Facilities from Citibank N.A.
 Exercise of 3000 Stock Options under Shalby Limited Employees Stock Options Scheme – 2021
 Exercise of 5,000 Stock Options under Shalby Limited Employees Stock Options Scheme - 2021
 Audio Recording of Investors Conference Call – 29-05-2024
 Declaration pursuant to Regulation 33(3 (d) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
 Recommendation of Dividend for the financial year 2023‐2024
 Intimation of Grant of Options under Shalby Limited Employees Stock Options Scheme – 2021
 Schedule of Investor Conference Call to discuss Q4 FY 2023-24 results – 29th May 2024
 Issuance of Corporate Guarantee for credit facilities amounting to Rs. 42 crore granted to Mars Medical Devices Limited (wholly‐owned subsidiary company)
 Allotment by SAT India to SAT Inc, USA
 Exercise of Stock Options under Shalby Limited Employees Stock Options Scheme - 2021
 Annual Secretarial Compliance Report FY 2023-24
 Issuance of Corporate Guarantee amounting to Rs. 55.85 crore for Credit facilities granted to PK Healthcare Pvt. Ltd. (Subsidiary Company)
 Availing credit facilities from IndusInd Bank Ltd
 Certificate ur. 7(3) - FY 2024
 Certificate ur. 74(5) - Q4 FY 2024
 Certificate under 40(10)
 Reconciliation of Share Capital Audit Report Q4 FY 2023-24
 Completion of Acquisition of 100% Equity Stake in Healers Hospital Pvt. Ltd
 Availing Term Loan of Rs. 100 crore from Bajaj Finance Ltd for acquisition of 100% stake in Healers Hospital
 Acquisition of 100% equity stake in Healers Hospital Pvt. Ltd.
 Disclosure under Reg 7(2) of SEBI (PIT) Reg, 2015 – 07-03-2024
 Disclosure under Reg 29(2) of SEBI (SAST) Reg, 2011 – 07-03-2024
 Notice to MMDL from Customs Dept
 Recording of Conference call – 12-02-2024
 Grant of ESOP
 Concall Invite Q3 FY 2023-24
 Change in Senior Management - Resignation of Chief Business Officer
 Closure of Corporate Guarantee
 PK Healthcare Pvt. Ltd. become subsidiary of Shalby Ltd.
 Exercise of Stock Options under Shalby Limited Employees Stock Options Scheme - 2021
 Acquisition of 87.26% stake in PK Healthcare Pvt. Ltd. (Sanar International Hospitals)
 Dr. Vikram Shah, CMD awarded with Prestigious Healthcare Entrepreneur Award by Hurun
 Shalby Academy – Signing of MoU with Kaushalya, Skill University of the Government of Gujarat, at Vibrant Gujarat Global Summit 2024
 Appointment of Global Chief Business Officer
 Reaffirmation and Assignment of Credit Rating
 Reconciliation of Share Capital Audit Report Q3 FY 2023-24
 Certificate ur. 74(5) – Q3 FY 2023-24
 Closure of Trading Window for Q3 FY 2023-24
 Further Investment by MMDL in SGTPL (December 2023)
 Availing enhanced SBLC facilities
 Investor Meet on 06-12-2023
 Exercise of Stock Options under Shalby Limited Employees Stock Options Scheme - 2021
 Investor Meet 05-12-2023 at Singapore
 Participating in Road Show at Singapore on 04-12-2023
 Intimation of Change in Senior Management
 Execution of Amendment Agreement with BCJ Hospital (Santacruz)
 Recording of Conference call – 30-10-2023
 Healthcare Personality of the Year Award 2023 (FICCI) to Our CMD, Dr. Vikram Shah
 Grant of ESOP
 Concall Invite Q2 FY 2023-24
 Update On Pending Material Litigation - Order Passed By Statutory Authority
 Reconciliation of Share Capital Audit Report Q2 FY 2023-24
 Certificate ur. 74(5) – Q2 FY 2023-24
 Intimation to investors on Online Dispute Resolution (ODR) Mechanism
 Closure of Trading Window for Q2 FY 2023-24
 Further Investment by MMDL in SGTPL (Sept 2023)
 Allotment of Preference Shares by MMDL to Shalby
 Analyst Meet with New Varnon Capital
 Signing of MoU with Sardar Vallabhbhai Global University by Shalby Academy (a Unit of Shalby Ltd.)
 Investment by Mars Medical Devices Limited in its subsidiary (SAT) by way of Preference Stock
 Secretarial Compliance
 Clarification to NSE for delay in disclosure of Transcript of Earning Conference Call
 Clarification to NSE for spurt in volume
 Clarification to BSE for spurt in volume
 Agreement for SOCE-Ranchi
 Participation in Conference call – IIFL Securities
 Closure of Trading Window for Q1 FY 2023-24
 Certificate ur. 74(5) – Q1 FY 2023-24
 Reconciliation of Share Capital Audit Report Q1 FY 2023-24
 Grant of ESOP
 Concall Invite Q1 FY 2023-24
 Clarification to NSE regarding Corporate Governance Report Q1 FY2023-24
 Clarification to BSE regarding Shareholding Pattern Q1 FY2023-24
 Analyst Meet with Motilal Oswal Asset Management
 Inauguration of Hospital at Ranchi
 Disclosure - Details of Pending Material Litigation(s) / Disputes
 Clarification to BSE regarding Corporate Governance Report Q1 FY2023-24
 Investor / Analyst Meet – 05-09-2023
 Clarification to NSE for spurt in volume
 Signing of MoU with P P Savani University by Shalby Academy
 Intimation to Shareholders for updation of KYC/PAN/Nomination
 Initial disclosure on large corporates
 Reappointment of Auditors for Second term
 Disclosure u/r. 30(5) of SEBI LODR for determining criteria & Disclosure of materiality of events
 Change in KMP
 Appointment of Independent Director
 Dividend announcement
 Concall Invite Q4 FY 2022-23
 concall recording Q4 FY2022-23
 Concall Invite Q4 FY2023
 Outcome of Board Meeting for year ended March 31, 2023
 Certificate under 40(10)
 Reconciliation of Share Capital Audit Report Q4 FY 2022-23
 Certificate ur. 74(5) – Q4 FY 2023
 Certificate ur. 7(3) - FY 2023
 Closure of Trading Window for Q4 FY 2022-23
 Allotment of Preference Shares to Shalby Ltd by Mars Medical Devices Limited
 Further Investment by MMDL in SGTPL (Mar 2023)
 Signing of MOU with Silver Oak University by Shalby Academy.
 Schedule of Investor Meet (Feb 2023)
 Receipt of Import License by Step-down subsidiary – Shalby Global Technologies Pte. Ltd., Singapore
 Signing of MOU with IIPH Gandhinagar by Shalby Academy
 Schedule of Investor / Analyst meet
 Update On Vrundavan Shalby Hospitals Limited - Wholly Owned Subsidiary
 Inauguration of Shalby Orthopedics Centre of Excellence (SOCE) at Gwalior
 Reconciliation of Share Capital Audit report Q3 FY 2022-23.
 93ScheduleConcall as Concall Invite Q3 FY 2023
 94Reg745 as Certificate ur. 74(5) – Q3 FY 2023
 Closure of Trading Window for Q3 FY2023
 Allotment to Shalby Ltd by Vrundavan Shalby Hospitals Ltd.
 Reaffirmation of Credit Rating
 Conversion of Loan of MMDL to SAT into Preferred Stock and Common Stock
 Schedule of Investor Meet (Dec 2022)
 Shalby Issued SBLC Amounting To USD 9.45 Million For Shalby Advanced Technologies
 Disclosure under Reg 29(2) of SEBI (SAST) Reg
 Disclosure under Reg 29(2) of SEBI (SAST) Reg
 Disclosure under Reg 29(2) of SEBI (SAST) Reg
 Demise of Mr. Kiritbhai Chimanlal Shah, Promoter Group
 Disclosure under Reg 29(2) of SEBI (SAST) Reg, 2011 – 29-11-2022
 Disclosure under Reg 7(2) of SEBI (PIT) Reg, 2015 – 29-11-2022
 Disclosure under Reg 29(2) of SEBI (SAST) Reg, 2011 – 17-11-2022
 Disclosure under Reg 7(2) of SEBI (PIT) Reg, 2015 – 17-11-2022
 Grant of ESOPs
 Newspaper Ad – Postal Ballot 2022
 Disclosure under Reg 7(2) of SEBI (PIT) Reg, 2015
 Disclosure under Reg 29(2) of SEBI (SAST) Reg, 2011
 Appointment of Mr. Parag Agarawal as Chief Business Officer
 Calendar of Events for Postal Ballot Process.
 Newspaper Advertisement for Q2 FY2023 Results
 Initial Disclosure under SEBI(PIT) Reg, by Mr. Vijay Kedia, director
 Appointment of Mr. Vijay Kedia as Additional Director (Non-Executive Non Independent).
 Re-appointment of Mrs. Sujana Shah as an Independent Director for second term w.e.f. 7th May 2023.
 Reconciliation of Share Capital Audit report
 Grant of Options under ESOP Scheme 2021 (Oct 2022)
 Concall Invite Q2 FY 2023
 Certificate ur. 74(5) – Q2 FY 2023
 Allotment of Equity & Preference Shares by MMDL to Shalby
 Closure of Trading Window Q2 FY2023
 Further Investment by MMDL in SGTPL (Aug 2022)
 Terms of Grant of Options
 Shalby Enters into Partnership with Australian Health Ed-Tech Company
 Concall Invite Q1 FY 2023
 Reconciliation of Share Capital Audit Report Q1 FY 2023
 Certificate ur. 74(5) – Q1 FY 2023
 Grant of Options under ESOP Scheme 2021 (Jul 2022)
 Disclosure under SEBI (SAST) Regulations, 2011 (14 Jun 2022)
 SEBI (Prohibition of Insider Trading) Reg.2015 (14 Jun 2022)
 Grant of Options under ESOP Scheme 2021 (Jun 2022)
 Disclosure under SEBI (SAST) Regulations, 2011 (Jun 2022)
 SEBI (Prohibition of Insider Trading) Reg. 2015 (Jun 2022)
 Annual Secretarial Compliance Report FY2021-22
 Acq. of Shares by Shalby Employees Welfare Trust (May 2022)
 Grant of Options Under ESOP Scheme 2021 (May 2022)
 Concall Invite Q4 FY2022
 Newspaper Advertisement for Q4 FY2022 Results
 Certificate under Reg. 40(10) of SEBI (LODR) – FY 2022
 Disclosure of Large Corporate (Apr 2022)
 Reconciliation of Share Capital Audit Report Q4 FY 2022
 Certificate ur. 74(5) – Q4 FY 2022
 Certificate ur. 7(3) - FY 2022
 Further Investment by MMDL in SGTPL (Mar 2022)
 Change in Name of Registrar & Transfer Agent (Mar 2022)
 Schedule of Investor-Analyst Meet (Mar 2022)
 Schedule of Group Investor-Analyst Meet (Mar 2022)
 Inauguration of SOCE in Ahmedabad (Mar 2022)
 Receipt of Import License to Subsidiary - MMDL (Feb 2022)
 Schedule of Investor-Analyst Meet Q3 FY2022
 Determining Materiality of an Event/Info by KMPs(Feb 2022)
 Appointment of Chief Financial Officer (Feb 2022)
 Further Investment by MMDL in SAT (Jan 2022)
 Certificate Under Reg. 74(5) Q3 FY 2022
 Reconciliation of Share Capital Audit Report Q3 FY 2022
 Resignation of Chief Financial Officer (Dec 2021)
 Further investment by MMDL in SGTPL (Dec 2021)
 Schedule of Investor-Analyst Meet (Nov 2021)
 Long Term Credit Rating for Enhanced Rated Amount (Nov 2021)
 Newspaper Advertisement for Q2 FY2022 Results
 Schedule of Investor-Analyst Meet Q2 FY2022
 Reconciliation of Share Capital Audit Report Q2 FY2022
 Upgradation of Credit Rating (Sep 2021)
 Revised Conference Call Invite (Aug 2021)
 Conference Call Invite (Aug 2021)
 Mars Medical Acquires 96% Shares in Shalby Global (Jul 2021)
 Reconciliation of Share Capital Audit Report Q1 FY2022
 Certificate Under Reg. 74(5) (Jun 2021)
 Reg. 30 of SEBl (LODR)- Inaugurated Shalby Zynova (Jun 2021)
 Annual Secretarial Compliance FY 2020-21
 Conference Call Invite & Investor Presentation (May 2021)
 Appointment of Vice Chairman & Global President (May 2021)
 Concall Invite for Audited Financials-Q4 & FY2021 (May 2021)
 Step-down Subsidiary in USA (May 2021)
 Newspaper Publication - Offer for Sale (Apr 2021)
 Disclosure of Large Corporate (Apr 2021)
 Intimation Of Subsidiary Company
 Con-call with Investors to address general queries about ongoing COVID-19 pandamic
 Con-call with Investors hosted by HDFS Sec to address general queries about ongoing COVID-19 pandemic
 Clarification Of Price MOvement To NSE
 Clarification Of Price MOvement To BSE
 Intimation of Testing of COVID-19 cases at Indore Shalby Hospital
 Con-call intimation hosted by Edelweiss
 Con-call intimation hosted by Edelweiss
 Compliance Certificate 7(3) – 31-03-2020
 Certificate under Reg.74(5) of SEBI (DP) Regulations, 2018
 Treatment of Covid-19 Patient at Shalby Hospital
 Conference call hosted by Centrum Broking Ltd.
 Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2019-20
 Reconciliation of Share Capital Audit Report Q4 FY 2019-20
 Disclosure as to Large Corporate
 Schedule of Investor / Analyst Meet Q4 FY20
 Trading Window Closure Notice For Q1 FY2021
 Intimation of Treatment of Covid-19 Patient at Shalby Hospital, Surat
 Intimation of Treatment of Covid-19 Patient at Shalby Hospital, Vapi
 Credit Rating ICRA Reg 30 LODR
 Certificate under Regulation 74 (5) Q1 2020-21
 Disclosure of impact of CoVID-19 on the business and operations
 Reconciliation of Share Capital Audit Report Q1 FY 2020-21
 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome”
 Announcement under Secretarial Compliance Report FY 2019-20”
 Aquisition Subsidiaries
 Investor Call Intimation
 Submission of newspaper ad for results Q1 FY2020-21
 Notice of 16th Annual General Meeting
 Intimation of Board of Directors Meeting
 Outcome of Board meeting
 Compliance Certificate 7(3) – 30-09-2020
 Certificate under Regulation 74 (5) Q2 2020-21
 Investor Conference Call Q2 F.Y. 2020-21
 Newspaper Ad for Results Q2 FY 2020-21
 Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2020-21
 Reconciliation of Share Capital Audit Report Q2 FY 2020-21
 Investor Analyst Call
 Intimation Of Subsidiary Company SHMPL
 Trading Window Closure
 Certificate under Regulation 74 (5) Q3 2020-21
 Schedule of Investor / Analyst Meet Q3 FY2021
 Shalby Limited Q3 FY2021 Press Release
 Reconciliation of Share Capital Audit Report Q3 FY 2020-21
 Investor / Analyst Meet
 Change in Company Secretary & Compliance Officer
 Disclosure under Regulation 30 (5) of the SEBl - LODR
 Annual Secretarial Compliance Report FY2021
 Reconciliation of Share Capital Audit Report Q4 FY2021
 Intimation of Trading Window Closure
 Compliance Certificate 7(3)-31-03-2019
 Intimation Of Analyst Meet
 Certificate under Regulation 40(10) of SEBI LODR –H2 FY 2018-19
 Reconciliation of Share Capital Q4 2018-19
 Interaction with electronic media
 Recommendation of Dividend for FY 2018-19
 Schedule of Investor / Analyst Meet Q4 FY19
 Submission of newspaper ad results Q4 FY2018-19
 Disclosure under SEBI PIT Reg. 7(2) 30.05.2019
 Disclosure under SEBI PIT Reg. 7(2) 01.06.2019
 Annual Secretarial Compliance Report FY 2018-19
 Intimation of Trading Window Closure
 Best IT enabled Hospital Award
 Reconciliation of Share Capital Q1 2019-20
 Certificate under Regulation 74 (5) Q1 2019-20
 Schedule of Investor Conference Call Q1 FY19
 News Paper Advertisement PAS-1 AGM
 Participation in Emkay Confluence at Mumbai – 08-Aug-2019
 Participation in Elara Annual Conference at Mumbai-– 05-September-2019
 Gujarat HealthCare Leadership Award 2019
 Intimation of Trading Window closure – Q2 FY 2019-20 Fin. Results
 Dare to Dream -Zee Business Award - Company of the Year
 Credit Rating ICRA Reg 30 LODR
 Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2019-20
 Clarification Of Price Movement
 Investor Con-call Q2 FY2019-20
 Press Release- Q2FY20 Financial Results
 Submission of newspaper ad results Q2 FY2019-20
 Change of name of Registrar & Transfer Agent
 Intimation of Trading Window closure – Q3 FY 2019-20 Fin. Results
 Compliance Certificate Q3 30-09-2019
 Reconciliation of Share Capital Audit Report Q3 FY 2019-20
 Change in Details of RTA
 Investor Con-call Q3 FY2019-20
 Clarification as to increase in volume of shares
 Re-appointment of CMD
 Submission of newspaper ad results Q3 FY2019-20
 Disclosure under SEBI PIT Reg. 7(2) 26.02.2020
 Statement of Investor Complaints – Q4 FY 2017-18
 Share Capital Audit – 31-03-2018
 Compliance Certificate under Reg. 7(3) of LODR
 Press Release – MoU with Sen Sok Intl Hospital, Cambodia
 Certificate under Regulation 40(10) of SEBI LODR
 Joint Replacement Surgeries under Mukhyamantri Amrutam Yojana
 Change in CIN
 Schedule of Investor / Analyst Meet
 Schedule of Investor / Analyst Meet – 27-04-2018
 Intimation Conference Call
 Intimation Appointment of CDSL as designated depository
 Collaboration with Berkeley Health Education
 Investor/Analyst meeting with Motilal Oswal Securities Limited
 Investors meet/UBS India- Midcap conference
 Resignation of Chief Executive Officer of the Company
 Intimation Analyst meet HDFC Securities 26-06-2018
 Updates relating to resignation of CEO
 Man of the Year Award – Dr. Vikram Shah
 Intimation Analyst meet – 26-06-2018
 Intimation Analyst meet - 27-06-2018
 Intimation Analyst meet - 02-07-2018
 Intimation Analyst meet – 06-07-2018
 Intimation Liver Disease and Transplantation
 Karvy Reconciliation Report
 Investor Grievance report
 Intimation of AGM
 Intimation of Book closure
 AGM Notice & Annual Report 2017-18
 Newspaper Ad. AGM, Book closure & E-voting
 Outcome of AGM
 Voting Results
 Shalby Press Release - Ovarian Mass Removal Jaipur
 Credit Rating ICRA Reg 30 LODR
 Reg 30 Orthotrends 2018 Chandigarh
 Intimation under Regulation 30 of SEBI LODR-concall with Edelweiss
 Investor Grievance Report Q2 FY 2018-19
 Share Capital Audit Q2 FY 2018-19
 Compliance Certificate 7(3) – 30-09-2018
 Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2018-19
 Pre Accreditation Entry level NABH at Shalby Surat
 Intimation for Conference call
 Submission of newspaper AD – Notice of Board Meeting
 Pre-Accreditation Entry level NABH at Shalby Naroda
 Newspaper ad for Issue of Duplicate Shares
 Intimation Analyst Meet – Nalanda Capital
 Intimation participation in IDFC Investor Conference
 Investor conference Kotak
 Intimation Issue of Duplicate Shares
 Press Release Kolkata
 Intimation Transfer of operations Karvy
 Medical Value Travel Specialist Hospital Award 2018
 Best hospital for Medical Tourism in Gujarat Award
 Share Capital Audit Q3 FY 2018-19
 Intimation of Investor Analyst Concall
 Intimation of Conference Call
 Intimation Analyst meet - DSP BlackRock Investment
 Newspaper ad for Q3 FY 2018-19 Results
 Disclosure under SEBI PIT Reg. 7(2)
 Announcement - Dr. Purvish Parikh as -Group Advisor
 Press Release - Radiation Therapy Centre, Jaipur
 Press Release - Radiation Therapy Centre, Naroda, Ahmedabad
 Authorization to KMP under Reg. 30 of SEBI LODR
 Statement of Investors Complaints – Q3 FY 2017-18
 Disclosure under SEBI PIT Reg. 7(2)
 Intimation about Loss of Share certificates
 Press Release – MoU with with Gleneagles Global Health City for Heart & Lung Transplants Program
Share Holder’s Meeting
Memorandum and Articles of Association
Terms of Appointment of Independent Directors
Code of Conduct for Directors & Senior Management
Vigil Mechanism Whistleblower Policy
Nomination and Remuneration Policy
Risk Management Policy
Policy on Criteria for Determining Materiality of Events
Policy for Preservation of Documents
Performance Evaluation Policy for BOD
Material Subsidiary Policy
Director Familiarisation Policy
Familiarization Program Imparted to Independent Directors
Corporate Social Responsibility (CSR) Policy
Related Party Transaction Policy
Business Responsibility & Sustainability Policy
Dividend Distribution policy
Prevention of Insider Trading
Policy on Leak of UPSI
Shalby Limited ESOP Scheme 2021
- Dr. Vikram Shah – Chairman & Managing Director, Shalby Limited at Edelweiss India Conference (Feb’18):
- Dr. Vikram Shah – Chairman & Managing Director, Shalby Limited at IIFL Enterprising India IX-2018 (Feb’18):
- A Special Episode in CNBC Awaaz – Incredible Journey – Rising stars
B-301/302,Mondeal Heights,
S. G. Highway,
Ahmedabad 380015,
Gujarat , India

